Application deadline for new drug, gene and biomarker discovery pilot and feasibility program is May 14
Apr. 17, 2012—The Vanderbilt Diabetes Research and Training Center announces a new pilot and feasibility program (P&F) for innovative studies that use the VICB High-Throughput Screening Facility, BioVU or the Mass Spectrometry Research Center for research on diabetes, obesity and metabolism. The application deadline is 9 a.m. on May 14. Application forms and detailed instructions can be obtained from...
Mar. 20, 2012—A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior.